Suppr超能文献

基于指纹图谱和化学计量学分析的中成药制备过程监测的判别成分追溯策略

Discriminatory components retracing strategy for monitoring the preparation procedure of Chinese patent medicines by fingerprint and chemometric analysis.

作者信息

Yao Shuai, Zhang Jingxian, Wang Dandan, Hou Jinjun, Yang Wenzhi, Da Juan, Cai Luying, Yang Min, Jiang Baohong, Liu Xuan, Guo De-an, Wu Wanying

机构信息

National Engineering Laboratory for TCM Standardization Technology, Shanghai Research Center for Modernization of Traditional Chinese Medicine, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Haike Road, Shanghai 201203, China.

出版信息

PLoS One. 2015 Mar 13;10(3):e0121366. doi: 10.1371/journal.pone.0121366. eCollection 2015.

Abstract

Chinese patent medicines (CPM), generally prepared from several traditional Chinese medicines (TCMs) in accordance with specific process, are the typical delivery form of TCMs in Asia. To date, quality control of CPMs has typically focused on the evaluation of the final products using fingerprint technique and multi-components quantification, but rarely on monitoring the whole preparation process, which was considered to be more important to ensure the quality of CPMs. In this study, a novel and effective strategy labeling "retracing" way based on HPLC fingerprint and chemometric analysis was proposed with Shenkang injection (SKI) serving as an example to achieve the quality control of the whole preparation process. The chemical fingerprints were established initially and then analyzed by similarity, principal component analysis (PCA) and partial least squares-discriminant analysis (PLS-DA) to evaluate the quality and to explore discriminatory components. As a result, the holistic inconsistencies of ninety-three batches of SKIs were identified and five discriminatory components including emodic acid, gallic acid, caffeic acid, chrysophanol-O-glucoside, and p-coumaroyl-O-galloyl-glucose were labeled as the representative targets to explain the retracing strategy. Through analysis of the targets variation in the corresponding semi-products (ninety-three batches), intermediates (thirty-three batches), and the raw materials, successively, the origins of the discriminatory components were determined and some crucial influencing factors were proposed including the raw materials, the coextraction temperature, the sterilizing conditions, and so on. Meanwhile, a reference fingerprint was established and subsequently applied to the guidance of manufacturing. It was suggested that the production process should be standardized by taking the concentration of the discriminatory components as the diagnostic marker to ensure the stable and consistent quality for multi-batches of products. It is believed that the effective and practical strategy would play a critical role in the guidance of manufacturing and help improve the safety of the final products.

摘要

中成药通常是按照特定工艺由几种中药制备而成,是中药在亚洲的典型剂型。迄今为止,中成药的质量控制通常集中于使用指纹图谱技术和多成分定量对最终产品进行评价,而很少关注对整个制备过程的监测,而后者被认为对确保中成药质量更为重要。在本研究中,以参芪注射液为例,提出了一种基于高效液相色谱指纹图谱和化学计量学分析的“溯源”新型有效策略,以实现对整个制备过程的质量控制。首先建立化学指纹图谱,然后通过相似度、主成分分析(PCA)和偏最小二乘判别分析(PLS-DA)进行分析,以评价质量并探索区分性成分。结果,识别出93批参芪注射液的整体不一致性,并将包括大黄素甲醚、没食子酸、咖啡酸、大黄酚-O-葡萄糖苷和对香豆酰-O-没食子酰-葡萄糖在内的5种区分性成分标记为代表性指标,以解释溯源策略。通过依次分析相应半成品(93批)、中间体(33批)和原材料中这些指标的变化,确定了区分性成分的来源,并提出了一些关键影响因素,包括原材料、共萃取温度、灭菌条件等。同时,建立了对照指纹图谱,并随后应用于生产指导。建议以区分性成分的浓度作为诊断标志物来规范生产过程,以确保多批次产品质量的稳定和一致。相信该有效实用的策略将在生产指导中发挥关键作用,并有助于提高最终产品的安全性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0dd/4359105/c1d6704f7a0f/pone.0121366.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验